Over the past 12 months, 0 insiders at Kinnate Biopharma Inc. filed 0 open-market SEC Form 4 transactions on KNTE: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 8, 23 | Foresite Capital Management Iv, LlcTenPercentOwner | BUY | 1.55M | $2.80 | $4.3M |
| May 8, 23 | James B. TananbaumDirector,TenPercentOwner | BUY | 1.55M | $2.80 | $4.3M |
| May 5, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 490.5K | $2.82 | $1.4M |
| May 5, 23 | Orbimed Advisors LlcDirector,TenPercentOwner | BUY | 490.5K | $2.82 | $1.4M |
| May 4, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 313.0K | $2.75 | $861K |
| May 4, 23 | Orbimed Advisors LlcDirector,TenPercentOwner | BUY | 313.0K | $2.75 | $861K |
| May 2, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 220.6K | $2.67 | $589K |
| May 2, 23 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 220.6K | $2.67 | $589K |
| May 1, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 467.1K | $2.62 | $1.2M |
| May 1, 23 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 467.1K | $2.62 | $1.2M |
| Apr 28, 23 | Carl L GordonDirector,TenPercentOwner | BUY | 228.8K | $2.55 | $583K |
| Apr 28, 23 | Orbimed Capital Gp VII LlcDirector,TenPercentOwner | BUY | 228.8K | $2.55 | $583K |
| Mar 14, 22 | Richard Thomas WilliamsChief Medical Officer | BUY | 25.0K | $8.37 | $209K |
| Mar 11, 22 | Richard Thomas WilliamsChief Medical Officer | BUY | 15.0K | $8.64 | $130K |
| Feb 15, 22 | Carl L GordonDirector | BUY | 9.0K | $9.96 | $90K |
| Feb 15, 22 | Orbimed Genesis Gp LlcDirector | BUY | 9.0K | $9.96 | $90K |
| Feb 14, 22 | Carl L GordonDirector | BUY | 20.7K | $9.98 | $207K |
| Feb 14, 22 | Orbimed Genesis Gp LlcDirector | BUY | 20.7K | $9.98 | $207K |
| Feb 11, 22 | Carl L GordonDirector | BUY | 156.0K | $10.22 | $1.6M |
| Feb 11, 22 | Orbimed Genesis Gp LlcDirector | BUY | 156.0K | $10.22 | $1.6M |
Over the past 12 months, insiders at Kinnate Biopharma Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on KNTE, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market KNTE insider purchase in our data was $4.3M by Foresite Capital Management Iv, Llc, TenPercentOwner, filed on May 8, 23.
0 different insiders at Kinnate Biopharma Inc. filed open-market SEC Form 4 transactions on KNTE over the last 12 months.
InsiderTape plots every KNTE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Kinnate Biopharma Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →